Tailoring adjuvant treatment in patients with uterine cancer

Affiliations

¹ Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan 20133, Italy. Electronic address: giorgio.bogani@istitutotumori.mi.it.
² Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan 20133, Italy.

Comment

Giorgio Bogani et al. Lancet Oncol. 2018 Dec.

. 2018 Dec;19(12):e655.

doi: 10.1016/S1470-2045(18)30684-3.

¹ Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan 20133, Italy. Electronic address: giorgio.bogani@istitutotumori.mi.it.
² Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan 20133, Italy.

No abstract available

Comment in

Tailoring adjuvant treatment in patients with uterine cancer - Authors' reply.
Frumovitz M, Abu-Rustum NR. Frumovitz M, et al. Lancet Oncol. 2018 Dec;19(12):e656. doi: 10.1016/S1470-2045(18)30832-5. Lancet Oncol. 2018. PMID: 30507416 No abstract available.

Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial.
Frumovitz M, Plante M, Lee PS, Sandadi S, Lilja JF, Escobar PF, Gien LT, Urbauer DL, Abu-Rustum NR. Frumovitz M, et al. Lancet Oncol. 2018 Oct;19(10):1394-1403. doi: 10.1016/S1470-2045(18)30448-0. Epub 2018 Aug 22. Lancet Oncol. 2018. PMID: 30143441 Free PMC article. Clinical Trial.